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A 65-year-old woman with a history of syncope was diagnosed with hypertrophic cardiomyopathy.
She had previously undergone mastectomy of the left breast owing to breast cancer. Holter electro-
cardiogram (ECG) and monitor ECG revealed sick sinus syndrome (Type II) and non-sustained
ventricular tachycardia. Sustained ventricular tachycardia and ventricular ﬁbrillation were induced in
an electrophysiological study. Although the patient was eligible for treatment with a dual chamber
implantable cardioverter deﬁbrillator (ICD), venography revealed lack of the right superior vena cava (R-
SVC). Lead placement from the left subclavian vein would have increased the risk of lymphedema owing
to the patient's mastectomy history. Consequently, the deﬁbrillation lead was placed in the right
ventricle by direct puncture of the right auricle through the tricuspid valve. The atrial lead was sutured
to the atrial wall, and the postoperative course was unremarkable. Deﬁbrillation lead placement using a
transthoracic transatrial approach can be an alternative method in cases where a transvenous approach
for lead placement is not feasible.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Patients with fatal arrhythmias are routinely treated with
an implantable cardioverter deﬁbrillator (ICD), whereby lead
placement is performed transvenously. However, a transvenous
approach is limited in cases of venous occlusion or malformation.
This report describes a case in which the deﬁbrillation lead was
placed using a transthoracic transatrial approach owing to inade-
quate transvenous access due to lack of the right superior vena
cava (R-SVC).
2. Case report
A 65-year-old woman with a history of syncope and diastolic
dysfunction was diagnosed with hypertrophic cardiomyopathy, as
evaluated by echocardiography and myocardial biopsy. Although
she had no family history of sudden death or cardiomyopathy, she
had experienced syncope at the age of 42 years, which had not
been fully examined. She had previously undergone a mastectomy
of the left breast due to breast cancer. An electrocardiogram (ECG)
indicated unstable sinus node function and Holter ECG recording
revealed sinus arrest lasting up to 2.6 s (Fig. 1). Furthermore,
non-sustained ventricular tachycardia with a cycle length of
400 ms lasting for a maximum of 3 s was observed several times.
Transthoracic echocardiography showed asymmetric mural thick-
ening from the base of the mid-interventricular septum. The left
ventricular ejection fraction was recorded as 65%, and the left
ventricular end-diastolic and end-systolic diameters measured
48 mm and 23 mm, respectively. There were no ﬁndings indicative
of left ventricular dyssynchrony, while a thoracic MRI revealed
delayed enhancement within the hypertrophied interventricular
septum. The left ventricular outﬂow tract was observed to be free
of obstruction. During the electrophysiological study, ventricular
tachycardia induced by bursting stimuli from the right ventricular
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apex degraded to ventricular ﬁbrillation and was terminated by an
external deﬁbrillator. Although the indication of ICD therapy
seemed to be controversial, the patient consented to receive ICD
for fear of sudden death. She was eligible for dual chamber ICD
treatment to prevent sudden cardiac death and to create atrial
pacing for brachycardia. Lack of the R-SVC was indicated by
venography, and a CT scan revealed a right brachiocephalic vein
running into the left superior vena cava (L-SVC) (Fig. 2). Lead
insertion from the left subclavian vein was possible but there was
a risk of lymphedema owing to the patient's mastectomy history.
Although the greater pectoral muscle and subcutaneous fat were
preserved during mastectomy, the left breast was surgically
removed and the axillary lymph nodes were dissected. Therefore,
we elected to use a transthoracic transatrial approach for surgical
lead placement for ICD treatment. Thoracotomy was performed
during median sternotomy and leads were placed on the beating
heart. A scalpel was used to cut the center of a small purse-string
suture on the right auricle, and a deﬁbrillation lead was positioned
in the right ventricle via the tricuspid valve. Bleeding around the
lead was well controlled and diminished by the purse-string
suture. An epicardial atrial lead was sutured to the atrial wall
(Fig. 3) to overcome sinus bradycardia. Oversensing was avoided
owing to the small size of the far-ﬁeld R wave. A subcutaneous
pocket was created in the left precordial area, and the leads were
passed from the pericardial cavity through the intercostal space to
the pocket and connected to a dual chamber ICD device designed
to deliver a maximum of 35 J (Fig. 4). We performed single
deﬁbrillation threshold testing (DFT) during the operation, and a
25-J shock successfully terminated ventricular ﬁbrillation (VF). We
did not perform DFT repeatedly in order to minimize the damage
to the heart under thoracotomy. The postoperative course and
12-month follow-up assessment were unremarkable.
3. Discussion
Transvenous ventricular lead placement is routinely used for ICD
treatment in patients with fatal arrhythmia. However, this approach
Fig. 1. Electrocardiogram on admission, indicating unstable sinus node function.
Fig. 2. A: Venography of the right subclavian vein illustrating lack of the right superior vena cava. The vein branching from the right subclavian vein is the azygos vein.
B: Three-dimensional computed tomography scan image of the right brachiocephalic vein running into the left superior vena cava. The right brachiocephalic vein is
compressed as it enters the left superior vena cava.
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is limited and an alternative procedure is required in complicated
cases such as those with venous occlusion or malformation, those
undergoing dialysis, or those with previous breast surgery.
Implantation of a deﬁbrillation patch under thoracotomy has
been used for implantation in the beginning and is still in use in
cases where venous access is inadequate, and studies have reported
Fig. 3. Intraoperative image (bottom is cranial) illustrating puncturing of the right auricle as a result of deﬁbrillation lead insertion. The epicardial atrial lead was sutured to
the atrial wall.
Fig. 4. Postoperative chest radiograph. The leads were passed from the pericardial cavity through the intercostal space and connected to a dual chamber implantable
cardioverter deﬁbrillator device in the left precordial area.
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postoperative heart failure in 3 of 35 ICD patients treated with a
deﬁbrillation patch [1]. In such cases, heart failure was considered
to be related with the epicardial patch, resulting in removal of the
patch. It is important to be attentive towards diastolic dysfunction
before surgery [2]. In our case, heart failure due to diastolic dysfunc-
tion was observed before surgery and an epicardial patch was
considered to be harmful for this patient. Subcutaneous ICD, which
is widely used in western countries, may be an alternative in cases
where sinus bradycardia is absent, but in our patient atrial pacing
would have been required with such an approach.
In this case, lead insertion from the left subclavian vein via the
L-SVC was feasible. Persistent left superior vena cava (PLSVC) is a
congenital venous malformation occurring in 0.3–0.5% of the
general population [3], but its presence in the absence of the R-
SVC is a very rare congenital anomaly [4]. ICD placement is a
complicated procedure in PLSVC cases, but is nevertheless still
feasible [5]. A report indicated that lymphedema occurs in
approximately 50% of cases with a history of mastectomy [6],
which in turn leads to a decrease in the patients' quality of life.
Lead implantation from the left subclavian vein via the L-SVC
would have been precarious owing to the increased risk of
lymphedema; therefore, lead implantation from the right subcla-
vian vein via the L-SVC was the alternative option. However, the
right brachiocephalic vein was compressed on entry into the L-SVC
leading to an increased risk of lead dislodgement and was there-
fore considered to be unfeasible. A transthoracic transatrial
approach was quite a distinct choice for lead placement, and
earlier reports of 35 patients who were treated in this way as the
transvenous approach was difﬁcult showed that 8 patients were
without any particular complications for up to 14 years [7,8]. We
chose this approach in our case, and the postoperative course was
uneventful.
Although our approach was successful, there is limited litera-
ture on the durability of the implanted lead using this method.
As a result, we continue to monitor the patient remotely to ensure
we are able to respond to any concerns with the lead in a timely
manner.
4. Conclusion
Deﬁbrillation lead placement using a transthoracic transatrial
approach can be a useful alternative in cases where lead place-
ment cannot be performed using a transvenous approach.
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